Prevention of Persistent Opioid Use in Mothers
CompletedPhase 4NCT03472521
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Our previous work has identified the group of women at risk for prolonged pain, opioid use and poor functional recovery after childbirth. The optimal intervention to mitigate this risk is unknown. We propose to test an analgesic adjutant that is commonly used for post-operative pain compared to placebo to improve post-partum recovery.
Study details
- Official title
- Prevention of Persistent Pain and Opioid Use in Mothers - POMS
- Conditions
- Opioid Use
- Postpartum Disorder
- Chronic Pain Syndrome
- Interventions
- Sponsor
- Stanford University
- Start date
- 2018-09-17
- Primary completion
- 2020-07-02
- Sex
- Female
- Age range
- from 18 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Delivery within 5 days, able to provide informed consent, English speaker Exclusion Criteria: * Opiate use disorder
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03472521